Recent studies indicated that TAM-like M2 macrophages enhanced resistance to anti-cancer drugs and the recruitment of immunosuppressive cells, such as Tregs and myeloid-derived suppressor cells (MDSCs), to the TME, and also that these effects were associated with LRRC8A [67,68]. Here, LRRC8A is linked to cancer.